6 December 2017 - - The global anti-aging drugs market to grow at a CAGR of 8.06% during the period 2017-2021, according to a report from Dublin-based Research and Markets.

According to the report, one of the major drivers for this market is growing disposable income and healthcare expenditure in developing countries.

Growing disposable income in developing countries such as India and China has attracted investors from around the world.

The latest trend gaining momentum in the market is Technological advancements. Continuous technological advancements are taking place in the global anti-aging drugs market.

Vendors have introduced advanced collagen-based materials such as bovine collagen and bioengineered human collagen, which contain lidocaine as dermal fillers.

Further, the report states that one of the major factors hindering the growth of this market is Side effects associated with facial aesthetic products use.

Despite being minimally invasive in nature, all medical procedures and the products used in the procedures have a defined set of risks as side effects.

The popular aesthetic products used in cosmetology such as BOTOX and dermal fillers also have their own set of side effects alog with the defined benefits.

Key vendors in this market include Allergan, Galderma, Merz Pharma and Sanofi. Other prominent vendors include Canbex Therapeutics, Daewoong Pharmaceutical, MMJ PhytoTech, Revitacare, SciVision Biotech, Sun Pharmaceuticals, Suneva Medical, Syneron and Valeant Pharmaceuticals.